Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
malaria vaccine
|
| gptkbp:administeredBy |
children
|
| gptkbp:approvalYear |
2023
|
| gptkbp:approvedBy |
gptkb:Burkina_Faso
gptkb:Ghana gptkb:Nigeria |
| gptkbp:associatedWith |
gptkb:RTS,S/AS01
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:containsAdjuvant |
gptkb:Matrix-M
|
| gptkbp:developedBy |
gptkb:University_of_Oxford
gptkb:Serum_Institute_of_India |
| gptkbp:effect |
up to 77%
|
| https://www.w3.org/2000/01/rdf-schema#label |
R-21
|
| gptkbp:storage |
2-8°C
|
| gptkbp:target |
malaria
|
| gptkbp:WHOStatus |
recommended
|
| gptkbp:bfsParent |
gptkb:Project_629
|
| gptkbp:bfsLayer |
6
|